Trials / Conditions / Relapsed or Refractory Solid Tumors
Relapsed or Refractory Solid Tumors
3 registered clinical trials studyying Relapsed or Refractory Solid Tumors.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7 NCT04447755 | Merck Sharp & Dohme LLC | Phase 2 |
| Terminated | Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small NCT02963610 | Fox Chase Cancer Center | Phase 1 / Phase 2 |
| Completed | A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors NCT01778439 | OncoMed Pharmaceuticals, Inc. | Phase 1 |